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INTRODUCTIONS:  Sweat  gland  carcinoma  is very  rare  with  a reported  incidence  of less than  0.005%  of  all
tumour  specimens  resected  surgically  (Tulenko  and  Conway,  1965)  [1].
CASE REPORT:  A  sixty  year  old  male  patient  presented  to us  with  a solitary  swelling  over  the  left chest
wall  since  two months.
DISCUSSION:  Cutaneous  apocrine  gland  carcinoma,  a  subtype  of  sweat  gland  carcinoma,  is  a  very  rare
malignant  neoplasm  arising  in  areas  of  high  apocrine  sweat  gland  density.
The  variability  of  the  histological  features  even  in  the  same  tumour,  and  its rarity,  have  contributed  toetastasis some  confusion  regarding  the  classiﬁcation  of  sweat  gland  carcinoma.
CONCLUSIONS:  Sweat  gland  carcinomas  are  a rare  group  of  tumours  with  potential  for  local  destruction
as  well  as distant  metastasis.  Wide  surgical  excision  along  with  regional  lymph  node  dissection  in the
presence  of  clinically  positive  nodes  is the recommended  treatment.  However,  a frequent  follow  up  is
essential  to detect  early  recurrence  as  well  as  distant  metastasis.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Sweat gland carcinoma is very rare with a reported incidence
f less than 0.005% of all tumour specimens resected surgically [1].
hey represent a group of tumours with potential for local tissue
nﬁltration and regional as well as distant metastasis. Due to limited
vailability of literature, the diagnosis as well as management of
hese tumours is quite difﬁcult. Here we present a case of an eccrine
arcinoma because of its rarity over the chest wall, its diagnosis and
anagement.
. Presentation of case
A sixty year old male patient presented to us with a solitary
welling over the left chest wall since two months, which was
pproximately 3 × 3 cm in size, slowly growing, painless, hard in
onsistency with smooth surface, on-mobile and not associated
ith discharge and axillary lymphadenopathy (shown in Fig. 1).
ll routine investigations were within normal limit Fine Needle
spiration (FNAC) of the lesion was positive for carcinoma cells
uggestive of adenocarcinoma. CT scan was done and it was sugges-
ive of well-deﬁned round to oval peripheral enhancing soft tissue
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lesion involving left anterolateral chest wall with cortical break and
erosion of the 6th and 7th ribs suggestive of neoplastic etiology.
2.1. Management
We managed the case with wide excision of the swelling with
segmental excision of the involved segments of the ribs with pleura
followed by a Delto-Pectoral fasciocutaneous ﬂap with insertion of
an intercostal drain (shown in Fig. 2). Histopathology report con-
ﬁrmed an eccrine carcinoma with involvement of the ribs(shown in
Fig. 3). The tumour cells immunohistochemical study showed that
tumour cells were positive for pancytokeratin/CK7/Calretinin with
focal luminal immunoreactivity for CEA (shown in Fig. 4). Based
on the above characteristic morphologic and immunohistochemi-
cal ﬁndings, the diagnosis of primary Eccrine adenocarcinoma was
made. We  lost the follow up of the patient after 3 months.
3. Discussion
Sweat glands are of two  types:
- Eccrine sweat glands open directly onto the surface of the skin
and are widely distributed almost everywhere.- Apocrine sweat glands are found in the armpit, areola, perineum,
ear and in the eyelid. Rather than opening directly onto the sur-
face of the skin, they secrete sweat into the pilary canal of the hair
follicle.
iates Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. shows solitary swelling over the left chest wall
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Fig. 3. Microphotograph (H&E) sectionFig. 2. shows Delto-Pectoral fasciocutaneous ﬂap
Sweat gland carcinomas represent a rare group of tumours with
otential for destructive local tissue inﬁltration and regional as
ell as distant metastasis. The management of these neoplasms
s both complex and cumbersome, mainly due to limited availabil-
ty of literature. Histological resemblance to the mature gland in
iopsy specimen contributes, but diagnosis is primarily based on
mmunohistochemistry or ultrastructural features. These tumours,
herefore, can be considered as clinico-pathological dilemmas with
n unpredictable biological behaviour. Rarely diagnosed clinically,
hey are often encountered as operative and histological surprises
2–6].
Sweat gland carcinomas occur primarily in adult patients, with
 peak incidence in ﬁfth and sixth decades of life [3,7,8]. Major-
ty occur in the genital skin and perineum (34.5%), followed by
runk (26.4%), head and neck (18.3%) and lower extremities (13.9%)
3,6,7,9].
Some problems are related to the classiﬁcation of sweat gland
arcinomas, which are currently classiﬁed on the basis of the corre-
ponding classiﬁcation of benign sweat gland adenoma [10]. Such
n approach, however, poses several problems; for example,
(a) some carcinomas have no benign counterpart and do not ﬁt
the scheme (ductal carcinoma, adenoid cystic carcinoma, and
mucinous carcinoma);
b) poorly differentiated carcinomas can be diagnosed only when
a contiguous adenoma is found histologically;
(c) histologic classiﬁcation can be very complicated because ade-
nomas are numerous, and their classiﬁcation is complex;
d) terminology includes unusual and difﬁcult terms, deriv-
ing from the terminology used for adenomas (malignant
acrospiroma, porocarcinoma, hidradenocarcinoma, malignant
cylindroma, malignant spiradenoma, and syringocystadenocar-
cinoma) [11–14].Finally, recent studies have classiﬁed sweat gland carcinomas
nto eccrine and apocrine tumours [13,14].Fig. 4. Microphotograph immunohistochemical study showed that tumour cells
were positive for pancytokeratin
- Apocrine carcinomas manifest as non-tender single or multiple,
ﬁrm, rubbery or cystic masses with red to purple overlying skin
[3,6,9]. Tumour cells are PAS (periodic acid-schiff stain) positive
due to glycogen granules and diastase resistant [3].
- Eccrine gland carcinomas possess no distinctive clinical features
making diagnosis by gross appearance virtually impossible. They
usually manifest as non-tender, subcutaneous nodules, primarily
in elderly individuals. Individual malignant cells are rich in glyco-
gen and stain with PAS and are diastase sensitive with prevalent
nuclear changes and propensity for lymphatic invasion [8,9]. Sites
of sweat gland carcinoma metastasis include nodes, lungs, liver
and bone [3,9,15]. Metastatic deposits from undiagnosed visceral
and breast adenocarcinoma are virtually indistinguishable micro-
scopically from sweat gland carcinoma and must be considered
before a diagnosis of metastatic sweat gland carcinoma is made.
The recommended treatment of all subtypes of sweat gland
carcinomas is wide surgical excision along with regional lymph
node dissection in the presence of clinically positive nodes. Some
authors advocate prophylactic regional lymph node dissection,
especially in patients with recurrent lesions after wide excision or
with highly undifferentiated tumours. Sweat gland carcinomas are
radio resistant, and chemotherapy has been infrequently employed
[16]. Prognostic factors for sweat gland carcinoma are difﬁcult to
identify, again owing to the small number of reported cases. The
likely prognostic factors include size, histological type, lymph node
involvement and distant metastasis. A 10-year disease free survival
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ate of 56% in the absence of lymph node metastasis is observed
hich falls to 9% if nodes are involved [3,15–17].
. Conclusion
Sweat gland carcinomas are a rare group of tumours with poten-
ial for local destruction as well as distant metastasis. Wide surgical
xcision along with regional lymph node dissection in the presence
f clinically positive nodes is the recommended treatment. How-
ver, a frequent follow up is essential to detect early recurrence as
ell as distant metastasis.
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